Contact the clinic (08) 8212 3022

 

 

 

About Us

Clinical Trials

Adelaide Eye & Retina Centre are proud to be involved with a number of clinical trials. We are excited to be involved in the development of new treatments for retinal disease. Our current trials are:

Exonate Study

A Randomised, Double-Masked Vehicle-Controlled, Multiple Dose, Dose Escalation Study To Evaluate The Safety and Tolerability of EXN407 in Subjects With Centre Involved Diabetic Macular Oedema Secondary to Diabetes Mellitus.

Ripple-1 Study

Evaluation of Safety and Efficacy of the IBE-814 Intravitreal Implant in Patients With Diabetic Macular Oedema and Macular Oedema Due to Retinal Vein Occlusion.

HLX-04-O-WAMD Study

A Phase 3, Two-part (Open-label Followed by Randomized Double-masked Active Controlled) Study to Compare the Efficacy and Safety of HLX04-O Administered by Intravitreal Injection With Ranibizumab in Subjects With Wet Age Related Macular Degeneration (wAMD).

OAKS (APL2-304) Study – Recruitment Closed

A Phase 3, multicenter, randomized, double-masked, sham-controlled study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

MYLIGHT Study

A 52-week Multicenter, Randomized, Double-masked, 2-arm Parallel Study to Compare Efficacy, Safety and Immunogenicity of SOK583A1 to Eylea®, Administered Intravitreally, in Patients With Neovascular Age-related Macular Degeneration.

FM101 Study

Phase 1/2a, Randomized, Double-Masked, Placebo-Controlled, Multi-center Study Assessing the Safety, Tolerability, And Efficacy Of FM101 In Patients With Ocular Hypertension, And To Assess The Relative Bioavailability Of The FM101 Oral Tablet Formulation In Healthy Participants.

OTX-TKI Study

A Phase 1 Open-Label, Dose Escalation Study of OTX-TKI for Intravitreal Use in Subjects With Neovascular Age-Related Macular Degeneration (AMD).

COAST Study

A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Aflibercept, Compared With Aflibercept Alone, in Participants With nAMD.

Request an Appointment

For fastest service please call us by phone on:

(08) 8212 3022

Fax

For urgent referrals:

(08) 8212 3302

Email

Please email us for less urgent contact:

admin@adelaideeye.com.au

Adelaide Eye and Retina Centre

18 North Terrace, Adelaide.

We are located on the second floor.

18 North Terrace, Adelaide

Marion Eye and Retina Centre

530 Marion Road, Plympton Park.